Chinese robotics company Unitree has once again upended perceptions of what humanoid machines can achieve. Ahead of the World Robot Conference in Beijing (August 19–23, 2026), the corporation unveiled a humanoid prototype codenamed "Superman," whose physical parameters surpass human biological capabilities.

The new model's running speed reaches 12.66 m/s (about 45.5 km/h), and its standing vertical jump is 2 meters. For comparison: this is faster than the world sprint record and higher than typical elite athlete benchmarks. Notably, Unitree's engineers needed just over three months to develop this machine, though the company itself emphasizes that "Superman" is merely an experimental sample that will continue to be refined.

Investment frenzy and stock market debut

The "Superman" presentation is not just a technological show. It is a perfect PR move ahead of a historic listing. On August 19, 2026, Unitree shares will begin trading on the STAR Market of the Shanghai Stock Exchange. The IPO figures look phenomenal: the offering was oversubscribed by retail investors more than 8,000 times, with the chance of receiving shares at just 0.018%. The offering price is set at 150.8 yuan per share, valuing the company at approximately 61 billion yuan (~$9 billion). Through the process, Unitree plans to raise about 6.1 billion yuan (~$905 million) before fees.

Among the strategic backers are giants Tencent, Alibaba, and DeepSeek. The market is already pricing in success: the STAR50 index has risen about 15% from its early August three-month low, and offshore derivatives point to a strong debut.

Production scale and competition

Against the backdrop of the announcement, it is worth recalling Unitree's actual scale. As of July 2026, the company had produced a total of about 18,000 bipedal humanoid robots across various models. This makes it one of the absolute industry leaders, although competitor AgiBot recently challenged its primacy, sparking debates about counting methodologies in the sector.

My take: "Superman" is not just an engineering curiosity but a powerful signal to the market. The integration of cutting-edge robotics with financial capital through the IPO creates a precedent where a technological breakthrough is directly converted into valuation multiples. However, investors should remember: a prototype is not yet a mass-produced product, and the arms race in humanoid robotics is only gaining momentum. Whoever achieves industrial maturity first will gain not just market share but effectively a new labor infrastructure.